2009. The role of alemtuzumab in chronic lymphocytic leukaemia patients with p53 defects. Hematology Meeting Reports (formerly Haematologica Reports). 1, 5 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v1i5.638.